The future of asthma

British Medical Journal

Volumn 314, Issue 7073, 1997, Pages 45-49

  Hall, Ian P ^a,b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b Self Management Working Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE; VACCINE;

ALLERGY; ASTHMA; CELL ACTIVATION; CELL PROLIFERATION; DRUG DESIGN; FUTUROLOGY; GENE ISOLATION; GENE THERAPY; GENETIC SCREENING; HUMAN; INFLAMMATION; MASS MEDIUM; MEDICAL RESEARCH; MOLECULAR MODEL; PRIORITY JOURNAL; SECOND MESSENGER; SHORT SURVEY;

EID: 0031023851     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.314.7073.45     Document Type: Short Survey

References (6)

1. Sandford A, Weir T, Pare P. The genetics of asthma. Am] Respir Crit Care Med 1996:153:1749-65.
2. Daniles SE, Bhattacharrya S, James A, Leaves NI, Young A, Hill MR, et ai A genome-wide search for quantitative trait loci underlying asthma. Nature 1996;383:247-50.
3. Hall IP. β2 adrenoceptor polymorphisms: are they clinically important? Thorax 1996p 1:351-3.
4. I loidrth PH. Bradding P, Montefon S, Peroni D, Djukanovk R, Carroll MP, et al. Mucosal inflammation and asthma. Am] Respir Crit Care Med 199-4; 150:318-22.
5. Barnes PJ. Cytokines as mediators of chronic asthma. Am] Respir Crit Care Med 199'l;150:S 12-9.
6. Barnes PJ. Molecular biology of receptors in the respiratory tract. In: Chung KF, Barries PJ, eds. Pharmacology of the respiratory traft, lung biology in health and disease. Vol 67. New York: M Dekker, 1993:1-26.